1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > United States Biosimilars Industry 2015 Market Research Report

United States Biosimilars Industry 2015 Market Research Report

  • November 2015
  • -
  • QY Research Group
  • -
  • 138 pages

Summary


The United States Biosimilars Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biosimilars industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilars market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 143 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

United States Biosimilars Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Biosimilars
1.2 Classification of Biosimilars
1.2.1 Recombinant non-glycosylated proteins
1.2.2 Recombinant glycosylated proteins
1.2.3 Recombinant peptides
1.3 Applications of Biosimilars
1.4 Industry Chain Structure of Biosimilars
1.5 Industry Overview of Biosimilars
1.6 Industry Policy Analysis of Biosimilars
1.7 Industry News Analysis of Biosimilars

2 Manufacturing Cost Structure Analysis of Biosimilars
2.1 Bill of Materials (BOM) of Biosimilars
2.2 BOM Price Analysis of Biosimilars
2.3 Labor Cost Analysis of Biosimilars
2.4 Depreciation Cost Analysis of Biosimilars
2.5 Manufacturing Cost Structure Analysis of Biosimilars
2.6 Manufacturing Process Analysis of Biosimilars
2.7 China Price, Cost and Gross of Biosimilars 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Biosimilars Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Biosimilars Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Biosimilars Key Manufacturers in 2014

4 Production Analysis of Biosimilars by Regions, Type, and Applications
4.1 United States Production of Biosimilars by Regions 2010-2015
4.2 United States Production of Biosimilars by Type 2010-2015
4.3 United States Sales of Biosimilars by Applications 2010-2015
4.4 Price Analysis of United States Biosimilars Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Biosimilars 2010-2015

5 Consumption Volume and Consumption Value Analysis of Biosimilars by Regions
5.1 United States Consumption Volume of Biosimilars by Regions 2010-2015
5.2 United States Consumption Value of Biosimilars by Regions 2010-2015
5.3 United States Consumption Price Analysis of Biosimilars by Regions 2010-2015

6 Analysis of Biosimilars Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Biosimilars 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Biosimilars 2014-2015
6.3 Sales Overview of Biosimilars 2010-2015
6.4 Supply, Consumption and Gap of Biosimilars 2010-2015
6.5 Import, Export and Consumption of Biosimilars 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Biosimilars 2010-2015

7 Analysis of Biosimilars Industry Key Manufacturers
7.1 Hospira
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Hospira SWOT Analysis

7.2 Sandoz International(Division Of Novartis International )
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Sandoz International(Division Of Novartis International ) SWOT Analysis

7.3 Teva
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Teva SWOT Analysis

7.4 Roche
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Roche SWOT Analysis

7.5 Amgen
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Amgen SWOT Analysis

7.6 Biocon
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Biocon SWOT Analysis

7.7 Dr. Reddy's Laboratories
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Dr. Reddy's Laboratories SWOT Analysis

7.8 Celltrion
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Celltrion SWOT Analysis

7.9 Mylan
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Mylan SWOT Analysis

7.10 Actavis
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Actavis SWOT Analysis

7.11 Merck
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Merck SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Biosimilars Product Types
8.5 Market Share Analysis of Different Biosimilars Price Levels
8.6 Gross Margin Analysis of Different Biosimilars Applications

9 Marketing Trader or Distributor Analysis of Biosimilars
9.1 Marketing Channels Status of Biosimilars
9.2 Traders or Distributors of Biosimilars with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilars
9.4 United States Import, Export and Trade Analysis of Biosimilars

10 Development Trend of Biosimilars Industry 2016-2021
10.1 Capacity and Production Overview of Biosimilars 2016-2021
10.2 Production Market Share by Product Types of Biosimilars 2016-2021
10.3 Sales and Sales Revenue Overview of Biosimilars 2016-2021
10.4 United States Sales of Biosimilars by Applications 2016-2021
10.5 Import, Export and Consumption of Biosimilars 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Biosimilars 2016-2021

11 Industry Chain Suppliers of Biosimilars with Contact Information
11.1 Major Raw Materials Suppliers of Biosimilars with Contact Information
11.2 Manufacturing Equipment Suppliers of Biosimilars with Contact Information
11.3 Major Players of Biosimilars with Contact Information
11.4 Key Consumers of Biosimilars with Contact Information
11.5 Supply Chain Relationship Analysis of Biosimilars

12 New Project Investment Feasibility Analysis of Biosimilars
12.1 New Project SWOT Analysis of Biosimilars
12.2 New Project Investment Feasibility Analysis of Biosimilars

13 Conclusion of the United States Biosimilars Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Biosimilars
Table Product Specifications of Biosimilars
Table Classification of Biosimilars
Figure United States Sales Market Share of Biosimilars by Product Types in 2014
Table Applications of Biosimilars
Figure United States Sales Market Share of Biosimilars by Applications in 2014
Figure Industry Chain Structure of Biosimilars
Table United States Industry Overview of Biosimilars
Table Industry Policy of Biosimilars
Table Industry News List of Biosimilars
Table Bill of Materials (BOM) of Biosimilars
Table Bill of Materials (BOM) Price of Biosimilars
Table Labor Cost of Biosimilars
Table Depreciation Cost of Biosimilars
Table Manufacturing Cost Structure Analysis of Biosimilars in 2014
Figure Manufacturing Process Analysis of Biosimilars
Table United States Price Analysis of Biosimilars 2010-2015 (USD/Dose)
Table United States Cost Analysis of Biosimilars 2010-2015 (USD/Dose)
Table United States Gross Analysis of Biosimilars 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Biosimilars Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Biosimilars Manufacturers in 2014
Table RandD Status and Technology Source of United States Biosimilars Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Biosimilars Key Manufacturers in 2014
Table United States Production of Biosimilars by Regions 2010-2015 (Doses)
Table United States Production Market Share of Biosimilars by Regions 2010-2015
Figure United States Production Market Share of Biosimilars by Regions in 2014
Figure United States Production Market Share of Biosimilars by Regions in 2015
Table United States Production of Biosimilars by Types in 2010-2015 (Doses)
Table United States Production Market Share of Biosimilars by Type in 2010-2015
Figure United States Production Market Share of Biosimilars by Type in 2014
Figure United States Production Market Share of Biosimilars by Type in 2015
Table United States Sales of Biosimilars by Applications 2010-2015 (Doses)
Table United States Production Market Share of Biosimilars by Applications 2010-2015
Figure United States Production Market Share of Biosimilars by Applications in 2014
Figure United States Production Market Share of Biosimilars by Applications in 2015
Table Price Comparison of United States Biosimilars Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Biosimilars 2010-2015
Table United States Consumption Volume of Biosimilars by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Biosimilars by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Biosimilars by Regions in 2014
Figure United States Consumption Volume Market Share of Biosimilars by Regions in 2015
Table United States Consumption Value of Biosimilars by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Biosimilars by Regions 2010-2015
Figure United States Consumption Value Market Share of Biosimilars by Regions in 2014
Figure United States Consumption Value Market Share of Biosimilars by Regions in 2015
Table Consumption Price of Biosimilars by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Biosimilars 2010-2015 (Doses)
Table United States Capacity Market Share of Major Biosimilars Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Biosimilars 2010-2015 (Doses)
Table United States Production Market Share of Major Biosimilars Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Biosimilars 2010-2015 (Doses)
Table United States Sales Market Share of Major Biosimilars Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Biosimilars 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Biosimilars Manufacturers 2010-2015
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Biosimilars 2010-2015
Figure United States Capacity Utilization Rate of Biosimilars 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Biosimilars 2010-2015
Figure United States Production Market Share of Major Biosimilars Manufacturers in 2014
Figure United States Production Market Share of Major Biosimilars Manufacturers in 2015
Figure United States Sales Market Share of Major Biosimilars Manufacturers in 2014
Figure United States Sales Market Share of Major Biosimilars Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Biosimilars 2010-2015
Table United States Supply, Consumption and Gap of Biosimilars 2010-2015 (Doses)
Table United States Import, Export and Consumption of Biosimilars 2010-2015 (Doses)
Table Price of United States Biosimilars Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Biosimilars Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Biosimilars 2010-2015 (M USD)
Table United States Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Hospira
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hospira 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Hospira 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Hospira 2010-2015
Table Hospira Biosimilars SWOT Analysis
Table Sandoz International(Division Of Novartis International ) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Sandoz International(Division Of Novartis International )
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sandoz International(Division Of Novartis International ) 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Sandoz International(Division Of Novartis International ) 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Sandoz International(Division Of Novartis International ) 2010-2015
Table Sandoz International(Division Of Novartis International ) Biosimilars SWOT Analysis
Table Teva Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Teva
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Teva 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Teva 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Teva 2010-2015
Table Teva Biosimilars SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Roche
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Roche 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Roche 2010-2015
Table Roche Biosimilars SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Amgen
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Amgen 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Amgen 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Amgen 2010-2015
Table Amgen Biosimilars SWOT Analysis
Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Biocon
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biocon 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Biocon 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Biocon 2010-2015
Table Biocon Biosimilars SWOT Analysis
Table Dr. Reddy's Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Dr. Reddy's Laboratories
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dr. Reddy's Laboratories 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Dr. Reddy's Laboratories 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Dr. Reddy's Laboratories 2010-2015
Table Dr. Reddy's Laboratories Biosimilars SWOT Analysis
Table Celltrion Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Celltrion
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celltrion 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Celltrion 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Celltrion 2010-2015
Table Celltrion Biosimilars SWOT Analysis
Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Mylan
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mylan 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Mylan 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Mylan 2010-2015
Table Mylan Biosimilars SWOT Analysis
Table Actavis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Actavis
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Actavis 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Actavis 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Actavis 2010-2015
Table Actavis Biosimilars SWOT Analysis
Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Biosimilars Picture and Specifications of Merck
Table Biosimilars Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2010-2015
Figure Biosimilars Capacity (Doses), Production (Doses) and Growth Rate of Merck 2010-2015
Figure Biosimilars Production (Doses) and United States Market Share of Merck 2010-2015
Table Merck Biosimilars SWOT Analysis
Table Biosimilars Price by Regions 2010-2015
Table Biosimilars Price by Product Types 2010-2015
Table Biosimilars Price by Companies 2010-2015
Table Biosimilars Gross Margin by Companies 2010-2015
Table Price Comparison of Biosimilars by Regions 2010-2015 (USD/Dose)
Table Price of Different Biosimilars Product Types (USD/Dose)
Table Market Share of Different Biosimilars Price Level
Table Gross Margin of Different Biosimilars Applications
Table Marketing Channels Status of Biosimilars
Table Traders or Distributors of Biosimilars with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilars (USD/Dose) in 2015
Table United States Import, Export, and Trade of Biosimilars (Doses)
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Biosimilars 2016-2021
Figure United States Capacity Utilization Rate of Biosimilars 2016-2021
Table United States Biosimilars Production by Type 2016-2021 (Doses)
Table United States Biosimilars Production Market Share by Type 2016-2021
Figure United States Production Market Share of Biosimilars by Type in 2021
Figure United States Sales (Doses) and Growth Rate of Biosimilars 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Biosimilars 2016-2021
Figure United States Sales of Biosimilars by Applications 2016-2021 (Doses)
Table United States Production Market Share of Biosimilars by Applications 2016-2021
Figure United States Production Market Share of Biosimilars by Applications in 2021
Table United States Production, Import, Export and Consumption of Biosimilars 2016-2021 (Doses)
Table United States Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Biosimilars 2016-2021
Table Major Raw Materials Suppliers of Biosimilars with Contact Information
Table Manufacturing Equipment Suppliers of Biosimilars with Contact Information
Table Major Players of Biosimilars with Contact Information
Table Key Consumers of Biosimilars with Contact Information
Table Supply Chain Relationship Analysis of Biosimilars
Table New Project SWOT Analysis of Biosimilars
Table New Project Investment Feasibility Analysis of Biosimilars
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...


Download Unlimited Documents from Trusted Public Sources

Biosimilar Industry in Europe

  • November 2016
    42 pages
  • Biosimilar  

  • Europe  

View report >

Pathology Statistics in Canada

  • October 2016
    2 pages
  • Biosimilar  

  • Canada  

    North America  

View report >

Global Breast Cancer Statistics

  • October 2016
    2 pages
  • Breast Cancer  

    Biosimilar  

  • Europe  

    World  

    Hungary  

View report >

Bioprocessing Industry

3 months ago

Biosimilar Statistics

3 months ago

Biosimilar Statistics

3 months ago

Related Market Segments :

Biosimilar

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.